TORONTO–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2023 (“Q2 Fiscal 2023”). All financial information in this press release is expressed in thousands of Canadian dollars (“$”), except for references to $ millions. “We are pleased with our results in a quarter with typical seasonality. Our market position remains competitive, supporte
The informative cannabis social network. Join groups, make friends and be part of the cannabis community! Share your recipes, product & strain reviews, tutorials and more! Log in or register to continue
Stock Ticker
- Loading stock data...
Categories
Recent Posts
- Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates
- Enveric Biosciences to Present Poster Highlighting EVM301 Series at the International Conference on Molecular Biology and Biochemistry 2023
- Method Man’s TICAL Official Cannabis Brand Launches in New York City
- LEXI Announces Appointment of Jason Nalewanyj as Chief Financial Officer and Highlights Significant Company Progress
- Aegis Sciences Corporation Further Expands Testing for Novel Psychoactive Substances
More from this user
